ReviewArchives of toxicology2026
Cysteine-based molecular switches: a focus on KEAP1 and BACH1 in regulating the antioxidant response.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Due to the chemical properties of their thiol groups and the surrounding amino acid environment, specific cysteines in proteins serve as the principal intracellular sensors for oxidants and electrophiles. In this review, we focus on the ubiquitin ligase substrate adaptor Kelch-like ECH-associated protein 1 (KEAP1) and the transcriptional repressor BTB and CNC homology 1 (BACH1) as representative cysteine-based molecular switches, both of which have critical functions in the cellular antioxidant response. KEAP1 is a protein endowed with a number of highly reactive cysteines, which can be covalently and preferentially modified by a wide array of reactive oxygen species, reactive nitrogen species and reactive electrophilic species, from endogenous as well as exogenous origin. Covalent cysteine modifications are also involved in the regulation of the localisation, stability and turnover of BACH1. Both KEAP1 and BACH1 antagonize the constitutively expressed transcription factor NF-E2 p45-related factor 2 (NRF2), the master regulator of the cellular antioxidant response, thus keeping the transcriptional activity of NRF2 low at homeostatic state. Cysteine modifications within KEAP1 and BACH1 render the repressor proteins inactive, resulting in rapid NRF2 activation that does not rely on de novo transcription of NFE2L2, the gene encoding NRF2. Consequently, NRF2 induces the transcriptional upregulation of a large network of genes encoding cytoprotective proteins, many of which have antioxidant functions, restoring the redox homeostasis.
Indexed as
Identifiers
42844347What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.